...
0,00  0

Basket

Žiadne produkty v košíku.

No products in the basket.

Continue shopping

Carnosine – a proven longevity factor

Numerous papers demonstrate the ability of carnosine to ward off the harmful effects of aging.

In youth, carnosine protects us from dangerous oxidative processes, glycation, DNA damage and other reactions that damage tissues and organs. 8 Over the course of life, however, carnosine levels in the body decline, 2-4 making us more susceptible to cognitive loss, reduced mobility, loss of metabolic control, cardiovascular disease, and increased risk of cancer. When carnosine was administered to various laboratory animals, their lifespan was prolonged. All of this contributes to changing conventional medicine’s perception of the aging process.

[div : clearfix]

[div]

Scientists investigate the link between carnosine and longevity

Carnosine is found in the body wherever there are higher energy requirements, such as in the brain, heart and muscles. 5 Its function is to protect these vital areas from metabolic demands to produce energy and manage energy requirements. 6,7

Young organisms have high levels of carnosine in precisely these energy-demanding tissues. With increasing age, carnosine levels decline.2-4 The reason for this is that our bodies produce less carnosine with increasing age, and also carnosine becomes more susceptible to destruction. When diseases such as diabetes and metabolic syndrome age the body unnaturally fast, carnosine production decreases and destruction increases. 8,9

These findings suggest that “carnosine deficiency” may be partly responsible for the visible aging and loss of function in numerous parts of the body that is associated with aging. If we could replenish carnosine levels in the body to baseline levels, we could halt at least part of the aging process.

Some of the most dramatic observations in recent years showing how supplementing carnosine prolongs life:

  1. Carnosine slows aging of human cells in vitro.10,11 Scientists have added carnosine to cultures of young cells. While the cells in the control culture showed signs of aging, those supplied with carnosine in high concentrations remained “young.”5 However, when these young-looking cells were transferred to a regular culture dish, they quickly reached the same age level as the control cells. As part of the experiment, the researchers picked out old cells at the end of their life cycle, transferred them to a culture medium containing high levels of carnosine, and found that these cells rejuvenated very quickly, approaching the young cells in appearance.10
  2. Carnosine extends the lifespan of whirligigs, which are microscopic aquatic animals that are used in many laboratories as a model of aging.12 In this experiment, the researchers examined many different antioxidants, identifying carnosine as one of four that had a significant effect on the longevity of the organisms.
  3. Carnosine extended the lifespan of wine flies, which are also used to study aging, by nearly 20% in male individuals.13,14 Normally, male individuals die much earlier than female individuals, but when carnosine was administered, male individuals reached the same age as female individuals.
  4. Carnosine prolonged the lifespan of laboratory mice, which share many characteristics with humans in terms of aging. 15,16

Scientists used a rapidly aging strain of mice and added carnosine to their diets. Not only did these animals live significantly longer, but they also retained the physical and behavioral traits of young individuals.15 They conducted the same experiment with normal mice and found a very similar effect in them. Carnosine clearly improved the appearance and condition of the carnosine-fed animals compared to those that did not receive carnosine.16

What you need to know: Carnosine provides a broad-spectrum defense against aging

  • Carnosine is a natural anti-aging component of the human body.
  • Carnosine counteracts such age-inducing processes as oxidation, glycation, protein cross-linking, telomere shortening,64 and the accumulation of modulated metals.
  • Carnosine levels decline with age, thereby progressively weakening defenses against age-related processes.
  • Carnosine supplementation can restore original carnosine levels in blood and tissues, and prolongs the lifespan of experimental animals.
  • Carnosine supplementation may protect against neurodegenerative diseases and defeat, also increases exercise performance, alleviates diabetes and its complications, and protects heart muscle and blood vessels from atherosclerosis.

Carnosine protects against cardiovascular diseases

The effects of carnosine are most pronounced in the heart and blood vessels, and carnosine has been shown to reduce mortality in stroke and mitigate its effects.17-19 Animal experiments have shown that carnosine administered before or after induced culling protects brain cells from so-called Ischemia-reperfusion injury, which occurs when there is a lack of oxygen in the tissue and its subsequent high levels after blood flow is restored.17,18 The beneficial effect of carnosine in this case leads to a reduction in oxidative damage to the cells and a real and significant reduction in the size of the area damaged by the injury.18

Carnosine also protects the heart muscle from ischemia (inadequate blood flow) causing heart attack. This protection is based on the antioxidant effect of carnosine, combined with its ability to scavenge oxidation-induced transition metals, its buffering capacity, and its effect on inflammatory cell activity.19 Carnosine has also been added to solutions used to protect heart muscle during heart surgery, when the heart is stopped and the risk of ischemic damage is very high.20

Carnosine also prevents ischemia in blood vessels, protecting blood vessel endothelial cells from oxidation and glycation, which are early signs of the development of atherosclerosis.21,22 Studies indicate that carnosine prevents the formation of dangerous foam cells, which are originally macrophagesfat-filled macrophages that trigger an inflammatory response leading to atherosclerotic plaque formation.23

Excessive muscle tone in blood vessels increases blood pressure and reduces blood flow in heart muscle and brain cells; carnosine reduces tone in blood vessels by multiple mechanisms.24 It modulates calcium ion signaling in smooth muscle cells that control vasculaturevascular tone and increase the production of beneficial endothelial NO synthetase, which induces a reduction in arterial tone.25

If we consider the beneficial effects of carnosine on skeletal muscle, then it is not surprising to find that carnosine also increases cardiac muscle contractility. Again, this is a multifactorial effect that is partly due to the ability of carnosine to control calcium flow and partly due to the antioxidant, buffering, and antiglycation properties of carnosine.19,26,27

Carnosine combats diabetes and its consequences

The global obesity epidemic carries with it the growing threat of type 2 diabetes and its devastating consequences – cardiovascular disease, kidney failure, nerve damage, and visual impairment.

Studies show that diabetic cells have carnosine levels below normal, similar to those of older adults.10 This may be one reason why diabetes causes accelerated aging.28

Thus, carnosine supplementation can restore the original early levels of carnosine in vital tissues, and offers protection against many of the complications of diabetes.

Carnosine lowers elevated blood sugar levels, reduces long-term formation of advanced glycation end products, limits oxidative stress and increased inflammatory activity and protein cross-linking not only in diabetics but also in otherwise healthy older adults.29-33

How carnosine protects against the destructive effects of elevated blood sugar on the body:

  • Carnosine protects kidney cells from the effects of high glucose levels, helping to reduce the risk of diabetic kidney disease, nephropathy.34-36
  • Carnosine reduces oxidation and glycation of low-density lipoprotein (LDL), which helps reduce the development of diabetes-induced atherosclerosis.37,23
  • Carnosine reduces the risk of cataracts (cataracts) in diabetics.38,39
  • Carnosine supplementation also acts as a preventive measure against damage to small blood vessels in the eye that causes diabetic retinopathy, a major cause of vision loss in diabetes.40
  • Carnosine supplementation prevents loss of sensory nerve function in diabetic animals.41

Carnosine protects brain cells, promotes cognitive function

Medication therapy in slowing cognitive decline has so far proven little effective. Treatments based on carnosine supplementation appear promising.42

Alzheimer’s disease is the most common and feared neurodegenerative disease. Researchers have found that Alzheimer’s patients have even lower levels of carnosine in the brain and cerebrospinal fluid than other older adults.43 It is not yet clear whether this is cause or effect, but many interesting observations suggest a role for carnosine in preventing the disease. Alzheimer’s disease is the result of many factors, virtually all of which are related to carnosine and its role in the brain. Well-known expert Alan R. Hipkiss of London’s Queen Mary’s School of Medicine and Dentistry recently summarized the relationship between Alzheimer’s disease and declining levels of carnosine in the body.

Hipkiss observed that the parts of the brain that are first affected by Alzheimer’s disease normally have the highest levels of carnosine.44 This suggests that as carnosine levels decline with age, it is these areas of the brain that are most vulnerable to Alzheimer’s-related damage. In addition, he notes that an abnormal protein, amyloid beta, present only in Alzheimer’s-affected brains, is full of zinc ions. Carnosine is able to bind zinc and thereby stop further tissue damage.44,45 Again, declining levels of carnosine expose brain tissue to an unnatural accumulation of toxic zinc.

Finally, Hipkiss notes that the so-called. The “neurofibrillary tangles” found in the brains of Alzheimer’s patients contain proteins that are extensively cross-linked.44 Carnosine is a potent inhibitor of protein cross-linking throughout the body.46

Mitochondrial dysfunction is another factor in Alzheimer’s disease; the oxidative stress associated with this dysfunction may be involved in the formation of the amyloid beta protein that is present in Alzheimer’s disease.47 Experimental studies in mice with Alzheimer’s disease have shown that supplementation with carnosine effectively reduces the accumulation of amyloid beta and completely protects their brains from mitochondrial dysfunction.31

In experimental models of neurodegenerative diseases associated with aging, these biochemical relationships show true results. Researchers fed aged mice a carnosine-rich diet that also contained vitamin D3, blueberries, and green tea polyphenols, or a control.48 The animals were trained to find their way to a platform submerged in water. At the end of the training period, the group of aged animals treated with carnosine had better results than a control group of the same aged untreated animals. The carnosine-fed animals were also found to show increased new brain cell formation, reduced inflammatory markers and brain cell deterioration compared to the control group. Similar antioxidant and anti-inflammatory effects were observed in the brains of mice with an experimental form of Parkinson’s disease.49

Stroke causes brain cell death caused by oxidative damage. Recent studies show that the antioxidant action of carnosine provides protection in ischemic stroke(insufficient blood supply to brain tissue) and haemorrhagic stroke (damage from bleeding).

In one study, rats were fed a mixture of carnosine, blueberries, green tea and vtiamine D3 for two weeks. They were then given an experimentally induced ischemic stroke in which a major cerebral blood vessel was surgically blocked.50 Behavioral testing before and after the procedure showed that, compared with controls, animals fed the mixture showed a 12% reduction in motor asymmetry, and a 24% reduction in neurological dysfunction after slaughter. These animals also exhibited a threefold higher rate of new brain cell proliferation after slaughter, compared to controls.

Other studies of ischemic stroke demonstrate a strong decrease in oxidative stress and brain cell apoptosis in animals that had carnosine added to their diets.51 Importantly, carnosine also provides protection after ischemia from so-called glutamate excitotoxicity, the same type of neuronal “exaggerated overdrive response” thought to contribute to the further development of Alzheimer’s disease.52

In experimental studies of hemorrhagic stroke, carnosine supplementation led to the restoration of physiological neurotransmitter receptors that had been damaged by the presence of blood in brain tissue.53 Carnosine also prevented the development of some of the dangerous edema that often follows hemorrhagic stroke.53

Carnosine targets six common mechanisms of molecular aging

Initially, scientists considered carnosine to be only an antioxidant molecule. But even though it has good antioxidant properties, carnosine is by no means the most powerful antioxidant in the body. What intrigued scientists is the fact that supplementation with other, more potent antioxidants did not result in as dramatic an increase in lifespan as supplementation with carnosine.62,65

Few researchers, however, have addressed the finding that carnosine does indeed interfere with the six major processes associated with aging. Let’s look at each of these to see how carnosine works overall.

  1. Oxidation at the cellular and tissue level is one of the major factors in aging. Carnosine scavenges oxygen and nitrogen free radicals and reduces their destructive effects on fat and DNA molecules.1,62,66,67 These effects each have a significant impact on stopping atherosclerosis and the development of cancer.
  2. Glycation, the formation of molecular glucose compounds with vital biomolecules such as enzymes and other proteins, is another major cause of aging. Glycated proteins induce severe oxidative stress and trigger inflammatory reactions that accelerate the aging process. Glycated proteins also form ‘cross-links’ that bind them together, reducing their flexibility and functionality. Instead of these biomolecules, carnosine itself undergoes the glycation process, sparing other vital structures, and preventing dangerous cross-linking of proteins.5,67,68
  3. Accumulation of excess metals44,69 Chelates of carnosine, its compounds with copper, zinc, and iron ions. Carnosine forms chelates, compounds with copper, zinc, and iron ions. These metals, when in excess, lead to the production of amyloid beta and other proteins that are present in Alzeimer’s and Parkinson’s disease.66,70-72
  4. Cross-linked proteins result from the accumulation of oxidative damage and glycation at a young age. They are eliminated by intracellular structures – proteasomes.65 With increasing age, however, proteasomal degradation decreases, allowing nonfunctional proteins to accumulate and interfere with cellular functionality. Carnosine is able to react with these abnormal proteins, thereby accelerating their elimination.65,70
  5. Telomeres are repetitive DNA sequences at the ends of chromosomes that function as a kind of “molecular clock” and shorten after each cycle of cell division. When telomeres shorten too much, cells die. Under experimental conditions, carnosine reduces damage to telomeres and slows their shortening.64
  6. Mitochondrial dysfunction-when mitochondria lose their efficiency, the aging process is accelerated by the fact that the cells are not supplied with enough energy and are subjected to a high oxidative load.47,73,74

Carnosine improves exercise performance

While excess fat increases the risk of diabetes, regular exercise reduces the risk of both diabetes and obesity. Carnosine promotes exercise performance by buffering rising acid levels that build up in stressed muscles.55,56 Acid buildup in muscles causes fatigue and pain, which ultimately limit exercise performance.54,57,58

Increased levels of carnosine present in muscle are now recognized as a means of improvingence in exercise performance and reducing fatigue, which is true for both trained and untrained individuals.6,59,60 This may be a critical factor in ensuring safety and independent living in the elderly, as frailty and risk of falls increase with muscle weakness.61

In a study of people aged 55-92 years, an increase in muscle carnosine levels resulted in a 29% increase in fatigue threshold compared with the pre-carnosine condition; no change in the control group.62 A similar study among 60-80 year olds showed a significant increase in the amount of time they spent exercising before becoming fatigued.63

Conclusion

The last decade has led to a wide range of findings regarding the multiple protective effects of carnosine that result from its ability to combat many of the processes that cause aging.

Carnosine protects against oxidative damage, glycation of vital proteins, the build-up of acidic substances in the muscles and heart, dangerousm transition metals, age-induced protein cross-linking, mitochondrial dysfunction and rapid telomere shortening.64

These diverse actions work together to prevent age-related diseases such as cognitive decline and dementia, promote comfort and heightcon during exercise, slow the progression of metabolic diseases such as diabetes, and work together to defend against atherosclerosis and heart disease. No wonder carnosine is referred to as an “anti-aging dipeptide. ” 26

Carnosine Extra, Carnosine, Carnosine, L-Carnosine

[container : text_content : References used]

  1. Hipkiss AR. Carnosine, a protective, anti-ageing peptide? Int J Biochem Cell Biol. 1998 Aug;30(8):863-8.
  2. Boldyrev AA, Yuneva MO, Sorokina EV, et al. Antioxidant systems in tissues of senescence accelerated mice. Biochemistry (Mosc). 2001 Oct;66(10):1157-63.
  3. Bellia F, Calabrese V, Guarino F, et al. Carnosinase levels in aging brain: redox state induction and cellular stress response. Antioxid Redox Signal. 2009 Nov;11(11):2759-75.
  4. Everaert I, Mooyaart A, Baguet A, et al. Vegetarianism, female gender and increasing age, but not CNDP1 genotype, are associated with reduced muscle carnosine levels in humans. Amino Acids. 2011 Apr;40(4):1221-9.
  5. Bellia F, Vecchio G, Cuzzocrea S, Calabrese V, Rizzarelli E. Neuroprotective features of carnosine in oxidative driven diseases. Mol Aspects Med. 2011 Aug;32(4-6):258-66.
  6. Baguet A, Bourgois J, Vanhee L, Achten E, Derave W. Important role of muscle carnosine in rowing performance. J Appl Physiol. 2010 Oct;109(4):1096-101.
  7. Calabrese V, Cornelius C, Cuzzocrea S, Iavicoli I, Rizzarelli E, Calabrese EJ. Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity. Mol Aspects Med. 2011 Aug;32(4-6):279-304.
  8. Riedl E, Koeppel H, Pfister F, et al. N-glycosylation of carnosinase influences protein secretion and enzyme activity: implications for hyperglycemia. Diabetes. 2010 Aug;59(8):1984-90.
  9. Gayova E, Kron I, Suchozova K, Pavlisak V, Fedurco M, Novakova B. Carnosine in patients with type I diabetes mellitus. Bratisl Lek Listy. 1999 Sep;100(9):500-2.
  10. McFarland GA, Holliday R. Retardation of the senescence of cultured human diploid fibroblasts by carnosine. Exp Cell Res. 1994 Jun;212(2):167-75.
  11. McFarland GA, Holliday R. Further evidence for the rejuvenating effects of the dipeptide L-carnosine on cultured human diploid fibroblasts. Exp Gerontol. 1999 Jan;34(1):35-45.
  12. Snell TW, Fields AM, Johnston RK. Antioxidants can extend the lifespan of Brachionus manjavacas (Rotifera), but only in a few combinations. Biogerontology. 2012 Jan 24.
  13. Yuneva AO, Kramarenko GG, Vetreshchak TV, Gallant S, Boldyrev AA. Effect of carnosine on Drosophila melanogaster life span. Bull Exp Biol Med. 2002 Jun;133(6):559-61.
  14. Stvolinsky S, Antipin M, Meguro K, Sato T, Abe H, Boldyrev A. Effect of carnosine and its Trolox-modified derivatives on life span of Drosophila melanogaster. Rejuvenation Res. 2010 Aug;13(4):453-7.
  15. Boldyrev AA, Gallant SC, Sukhich GT. Carnosine, the protective, anti-aging peptide. Biosci Rep. 1999 Dec;19(6):581-7.
  16. Gallant S, Semyonova M, Yuneva M. Carnosine as a potential anti-senescence drug. Biochemistry (Mosc). 2000 Jul;65(7):866-8.
  17. Dobrota D, Fedorova T, Stvolinsky S, et al. Carnosine protects the brain of rats and Mongolian gerbils against ischemic injury: after-stroke-effect. Neurochem Res. 2005 Oct;30(10):1283-8.
  18. Rajanikant GK, Zemke D, Senut MC, et al. Carnosine is neuroprotective against permanent focal cerebral ischemia in mice. Stroke. 2007 Nov;38(11):3023-31.
  19. Stvolinsky SL, Dobrota D. Anti-ischemic activity of carnosine. Biochemistry (Mosc). 2000 Jul;65(7):849-55.
  20. Bokeriya LA, Boldyrev AA, Movsesyan RR, et al. Cardioprotective effect of histidine-containing dipeptides in pharmacological cold cardioplegia. Bull Exp Biol Med. 2008 Mar;145(3):323-7.
  21. Hipkiss AR, Preston JE, Himswoth DT, Worthington VC, Abbot NJ. Protective effects of carnosine against malondialdehyde-induced toxicity toward cultured rat brain endothelial cells. Neurosci Lett. 1997 Dec 5;238(3):135-8.
  22. Bai J, Chi G, Zhang J, et al. Protective effect of carnosine on the injury of rat vascular endothelial cells induced by hypoxia. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2010 Feb;26(1):30-2.
  23. Rashid I, van Reyk DM, Davies MJ. Carnosine and its constituents inhibit glycation of low-density lipoproteins that promotes foam cell formation in vitro. FEBS Lett. 2007 Mar 6;581(5):1067-70.
  24. Ririe DG, Roberts PR, Shouse MN, Zaloga GP. Vasodilatory actions of the dietary peptide carnosine. Nutrition. 2000 Mar;16(3):168-72.
  25. Takahashi S, Nakashima Y, Toda K. Carnosine facilitates nitric oxide production in endothelial f-2 cells. Biol Pharm Bull. 2009 Nov;32(11):1836-9.
  26. Stock GP, Roberts PR, Nelson TE. Carnosine: a novel peptide regulator of intracellular calcium and contractility in cardiac muscle. New Horiz. 1996 Feb;4(1):26-35.
  27. Roberts PR, Zaloga GP. Cardiovascular effects of carnosine. Biochemistry (Mosc). 2000 Jul;65(7):856-61.
  28. Wu CH, Huang SM, Lin JA, Yen GC. Inhibition of advanced glycation endproduct formation by foodstuffs. Food Funct. 2011 May;2(5):224-34.
  29. Jakus V. The role of nonenzymatic glycation and glyco-oxidation in the development of diabetic vascular complications. Cesk Fysiol. 2003 May;52(2):51-65.
  30. Hipkiss AR. Glycation, aging and carnosine: are carnivorous diets beneficial? Mech Ageing Dev. 2005 Oct;126(10):1034-9.
  31. Nagai K, Niijima A, Yamano T, et al. Possible role of L-carnosine in the regulation of blood glucose through controlling autonomic nerves. Exp Biol Med (Maywood). 2003 Nov;228(10):1138-45.
  32. Hipkiss AR, Brownson C, Carrier MJ. Carnosine, the anti-aging, anti-oxidant dipeptide, may react with protein carbonyl groups. Mech Ageing Dev. 2001 Sep 15;122(13):1431-45.
  33. Aldini G, Facino RM, Beretta G, Carini M. Carnosine and related dipeptides as quenchers of reactive carbonyl species: from structural studies to therapeutic perspectives. Biofactors. 2005;24(1-4):77-87.
  34. Janssen B, Hohenadel D, Brinkkoetter P, et al. Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes. 2005 Aug;54(8):2320-7.
  35. Sauerhofer S, Yuan G, Braun GS, et al. L-carnosine, a substrate of carnosinase-1, influences glucose metabolism. Diabetes. 2007 Oct;56(10):2425-32.
  36. Riedl E, Pfister F, Braunagel M, et al. Carnosine prevents apoptosis of glomerular cells and podocyte loss in STZ diabetic rats. Cell Physiol Biochem. 2011;28(2):279-88.
  37. Lee YT, Hsu CC, Lin MH, Liu KS, Yin MC. Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation. Eur J Pharmacol. 2005 Apr 18;513(1-2):145-50.
  38. Yan H, Harding JJ. Carnosine protects against the inactivation of esterase induced by glycation and a steroid. Biochim Biophys Acta. 2005 Jun 30;1741(1-2):120-6.
  39. Yan H, Guo Y, Zhang J, Ding Z, Ha W, Harding JJ. Effect of carnosine, aminoguanidine, and aspirin drops on the prevention of cataracts in diabetic rats. Mol Vis. 2008;14:2282-91.
  40. Pfister F, Riedl E, Wang Q, et al. Oral carnosine supplementation prevents vascular damage in experimental diabetic retinopathy. Cell Physiol Biochem. 2011;28(1):125-36.
  41. Kamei J, Ohsawa M, Miyata S, Tanaka S. Preventive effect of L-carnosine on changes in the thermal nociceptive threshold in streptozotocin-induced diabetic mice. Eur J Pharmacol. 2008 Dec 14;600(1-3):83-6.
  42. Shen Y, Hu WW, Chen Z. Carnosine and diseases of central nervous system. Zhejiang Da Xue Bao Yi Xue Ban. 2007 Mar;36(2):199-203.
  43. Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG. Free amino acid and dipeptide changes in the body fluids from Alzheimer’s disease subjects. Amino Acids. 2007 Feb;32(2):213-24.
  44. Hipkiss AR. Could carnosine or related structures suppress Alzheimer’s disease? J Alzheimers Dis. 2007 May;11(2):229-40.
  45. Matsukura T, Tanaka H. Applicability of zinc complex of L-carnosine for medical use. Biochemistry (Mosc). 2000 Jul;65(7):817-23.
  46. Wang AM, Ma C, Xie ZH, Shen F. Use of carnosine as a natural anti-senescence drug for human beings. Biochemistry (Mosc). 2000 Jul;65(7):869-71.
  47. Corona C, Frazzini V, Silvestri E, et al. Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice. PLoS One. 2011;6(3):e17971.
  48. Acosta S, Jernberg J, Sanberg CD, et al. NT-020, a natural therapeutic approach to optimize spatial memory performance and increase neural progenitor cell proliferation and decrease inflammation in the aged rat. Rejuvenation Res. 2010 Oct;13(5):581-8.
  49. Tsai SJ, Kuo WW, Liu WH, Yin MC. Antioxidative and anti-inflammatory protection from carnosine in the striatum of MPTP-treated mice. J Agric Food Chem. 2010 Oct 6.
  50. Yasuhara T, Hara K, Maki M, et al. Dietary supplementation exerts neuroprotective effects in ischemic stroke model. Rejuvenation Res. 2008 Feb;11(1):201-14.
  51. Pekcetin C, Kiray M, Ergur BU, et al. Carnosine attenuates oxidative stress and apoptosis in transient cerebral ischemia in rats. Acta Biol Hung. 2009 Jun;60(2):137-48.
  52. Shen Y, He P, Fan YY, et al. Carnosine protects against permanent cerebral ischemia in histidine decarboxylase knockout mice by reducing glutamate excitotoxicity. Free Radic Biol Med. 2010 Mar 1;48(5):727-35.
  53. Khama-Murad A, Mokrushin AA, Pavlinova LI. Neuroprotective properties of l-carnosine in the brain slices exposed to autoblood in the hemorrhagic stroke model in vitro. Regul Pept. 2011 Feb 25;167(1):65-9.
  54. Begum G, Cunliffe A, Leveritt M. Physiological role of carnosine in contracting muscle. Int J Sports Nutr Exerc Metab. 2005 Oct;15(5):493-514.
  55. Baguet A, Koppo K, Pottier A, Derave W. Beta-alanine supplementation reduces acidosis but not oxygen uptake response during high-intensity cycling exercise. Eur J Appl Physiol. 2010 Feb;108(3):495-503.
  56. Sale C, Saunders B, Harris RC. Effect of beta-alanine supplementation on muscle carnosine concentrations and exercise performance. Amino Acids. 2010 Jul;39(2):321-33.
  57. Tallon MJ, Harris RC, Boobis LH, Fallowfield JL, Wise JA. The carnosine content of vastus lateralis is elevated in resistance-trained bodybuilders. J Strength Cond Res. 2005 Nov;19(4):725-9.
  58. Giannini Artioli G, Gualano B, Smith A, Stout J, Herbert Lancha AJ. The role of beta-alanine supplementation on muscle carnosine and exercise performance. Med Sci Sports Exerc. 2009 Dec 9.
  59. Derave W, Everaert I, Beeckman S, Baguet A. Muscle carnosine metabolism and beta-alanine supplementation in relation to exercise and training. Sports Med. 2010 Mar 1;40(3):247-63.
  60. Hobson RM, Saunders B, Ball G, Harris RC, Sale C. Effects of beta-alanine supplementation on exercise performance: a meta-analysis. Amino Acids. 2012 Jan 24.
  61. Stout JR, Graves BS, Smith AE, et al. The effect of beta-alanine supplementation on neuromuscular fatigue in elderly (55-92 Years): a double-blind randomized study. J Int Soc Sports Nutr. 2008;5:21.
  62. Hyland P, Duggan O, Hipkiss A, Barnett C, Barnett Y. The effects of carnosine on oxidative DNA damage levels and in vitro life span in human peripheral blood derived CD4+T cell clones. Mech Ageing Dev. 2000 Dec 20;121(1-3):203-15.
  63. Del Favero S, Roschel H, Solis MY, et al. Beta-alanine (Carnosyn) supplementation in elderly subjects (60-80 years): effects on muscle carnosine content and physical capacity. Amino Acids. 2011 Dec 6.
  64. Shao L, Li QH, Tan Z. L-carnosine reduces telomere damage and shortening rate in cultured normal fibroblasts. Biochem Biophys Res Commun. 2004 Nov 12;324(2):931-6.67.
  65. Hipkiss AR, Brownson C, Bertani MF, Ruiz E, Ferro A. Reaction of carnosine with aged proteins: another protective process? Ann N Y Acad Sci. 2002 Apr;959:285-94.
  66. Hipkiss AR, Preston JE, Himsworth DT, et al. Pluripotent protective effects of carnosine, a naturally occurring dipeptide. Ann N Y Acad Sci. 1998 Nov 20;854:37-53.
  67. Reddy VP, Garrett MR, Perry G, Smith MA. Carnosine: a versatile antioxidant and antiglycating agent. Sci Aging Knowledge Environ. 2005 May 4;2005(18):pe12.
  68. Hipkiss AR, Michaelis J, Syrris P. Non-enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross-linking agent. FEBS Lett. 1995 Aug 28;371(1):81-5.
  69. Kang JH. Protective effects of carnosine and homocarnosine on ferritin and hydrogen peroxide-mediated DNA damage. BMB Rep. 2010 Oct;43(10):683-7.
  70. Hipkiss AR. On the enigma of carnosine’s anti-aging actions. Exp Gerontol. 2009 Apr;44(4):237-42.
  71. Hipkiss AR. Carnosine and its possible roles in nutrition and health. Adv Food Nutr Res. 2009;57:87-154.
  72. Boldyrev AA, Stvolinsky SL, Fedorova TN, Suslina ZA. Carnosine as a natural antioxidant and geroprotector: from molecular mechanisms to clinical trials. Rejuvenation Res. 2010 Apr-Jun;13(2-3):156-8.
  73. Cheng J, Wang F, Yu DF, Wu PF, Chen JG. The cytotoxic mechanism of malondialdehyde and protective effect of carnosine via protein cross-linking/mitochondrial dysfunction/reactive oxygen species/MAPK pathway in neurons. Eur J Pharmacol. 2011 Jan 10;650(1):184-94.
  74. Hipkiss AR. Aging, proteotoxicity, mitochondria, Glycation, NAD and Carnosine: Possible Inter-relationships and resolution of the oxygen paradox. Front Aging Neurosci. 2010;2:10.

[container : end]

We have translated this article for you from the source www.lifeextension.com

Opening hours

Monday
09.00 - 17.00 hod.
Tuesday
09.00 - 17.00 hod.
Wednesday
09.00 - 17.00 hod.
Thursday
09.00 - 17.00 hod.
Friday
09.00 - 17.00 hod.

Our socials

Registrácia

Prihlásenie